细胞增殖（英文）（Cell Proliferation）（国际刊号） （官网投稿）

万维提示：

1、该刊只有国际刊号！

2、投稿方式：在线投稿。

3、官网网址：

https://onlinelibrary.wiley.com/journal/13652184

4、投稿系统：

https://wiley.atyponrex.com/journal/CPR

5、官网邮箱：CPReditorialoffice@wiley.com

6、出刊日期：月刊，一年出版12期。

2026年1月29日星期四

Author Guidelines

【官网信息】

1. Submission and Peer Review Process

Thank you for your interest in Cell Proliferation. Please note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting on symposium.

New submissions should be made via the Research Exchange submission portal https://wiley.atyponrex.com/journal/CPR. You may check the status of your submission at any time by logging on to submission.wiley.com and clicking the "My Submissions" button. For technical help with the submission system, please review our FAQs or contact submissionhelp@wiley.com.

For help with submissions, please contact: CPReditorialoffice@wiley.com

1.1 Article Preparation Support

Wiley Editing Services offers expert help with English Language Editing, as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design – so you can submit your manuscript with confidence.

Also, check out our resources for Preparing Your Article for general guidance about writing and preparing your manuscript.

1.2 Free Format Submission

Cell Proliferation offers Free Format submission for a simplified and streamlined submission process.

Before you submit, you will need:

Your manuscript: this should be an editable file including text, figures, and tables, or separate files—whichever you prefer. All required sections should be contained in your manuscript, including abstract, introduction, methods, results, and conclusions (For details, see Section 2). Figures and tables should have legends. Figures should be uploaded in the highest resolution possible (For details, see Section 1.11). If the figures are not of sufficiently high quality, your manuscript may be delayed. References may be submitted in any style or format, as long as it is consistent throughout the manuscript. Supporting information should be submitted in separate files. If the manuscript, figures or tables are difficult for you to read, they will also be difficult for the editors and reviewers, and the editorial office will send it back to you for revision. Your manuscript may also be sent back to you for revision if the quality of English language is poor.

1.3 Open Access

This journal is a Gold Open Access journal. Submissions will be subject to an APC if accepted and published in the journal. You can read more about APCs and whether you may be eligible for waivers or discounts, through your institution, funder, or a country waiver. For more information on this journal’s APCs and licensing policy, please visit the journal’s Open Access page.

1.4 Preprint Policy

Please find the Wiley preprint policy here.

This journal accepts articles previously published on preprint servers.

Cell Proliferation will consider for review articles previously available as preprints. You are requested to update any pre-publication versions with a link to the final published article. You may also post the final published version of the article immediately after publication.

1.5 Data Policies

When you submit a manuscript to this journal, it is imperative to follow the guidelines regarding data sharing, citation, and protection as outlined below:

Data Sharing and Availability

This journal expects and peer reviews data sharing. Review Wiley’s Data Sharing Policy where you will be able to see and select the data availability statement that is right for your submission.

Data Citation

Please review Wiley’s Data Citation Policy.

Data Protection

By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication. Please review Wiley’s Data Protection Policy to learn more.

1.6 Funding

You should list all funding sources in the Acknowledgments section. You are responsible for the accuracy of their funder designation. If in doubt, please check the Open Funder Registry for the correct nomenclature.

1.7 Authorship, Pronouns, and ORCID

Authorship

All listed authors should have contributed to the manuscript substantially and have agreed to the final submitted version. Review editorial standards and scroll down for a description of authorship criteria.

Author Pronouns

Authors may now include their personal pronouns in the author bylines of their published articles and on Wiley Online Library. Authors will never be required to include their pronouns; it will always be optional for the author. Authors can include their pronouns in their manuscript upon submission and can add, edit, or remove their pronouns at any stage upon request. Submitting/corresponding authors should never add, edit, or remove a coauthor’s pronouns without that coauthor’s consent. Where post-publication changes to pronouns are required, these can be made without a correction notice to the paper, following Wiley’s Name Change Policy to protect the author’s privacy. Terms which fall outside of the scope of personal pronouns (e.g. proper or improper nouns), are currently not supported.

ORCID

An ORCID ID, freely available at https://orcid.org. (Why is this important? Your article, if accepted and published, will be attached to your ORCID profile. Institutions and funders are increasingly requiring authors to have ORCID IDs.)

This journal requires the submitting author (only) to provide an ORCID iD when submitting a manuscript. This takes around 2 minutes to complete. Please refer to Wiley’s resources on ORCID.

1.8 Reproduction of Copyright Material

If excerpts from copyrighted works owned by third parties are included, all sources must be credited within the manuscript. At minimum, the title and author should be provided.

The corresponding author is responsible for obtaining written permission to reproduce the material "in print and other media" from the publisher of the original source, and for supplying Wiley with that permission upon request

For more information, review Wiley’s Guidelines for Obtaining Permission to Reproduce Material.

1.9 Title Page

The title page of the manuscript, including: Your co-author details, affiliation, email address, and so on. (Why is this important? We need to keep all co-authors informed of the outcome of the peer review process.)

Title: A brief informative title containing the major key words. The title should not contain abbreviations.

Authors: The full names of the authors Please provide institutional email address for corresponding author(s)

Affiliations: The author's institutional affiliations where the work was conducted, with a footnote for the author’s present address if different from where the work was conducted, for example: “1 [Department/Institute], [University], [City] [Postal code], [Country]”.

A short running title of less than 40 characters (optional);

1.10 Main Text

Abstract: Abstract structured (introduction/methods/results/conclusion) or unstructured, less than 300 words;

Keywords: Up to seven keywords;

Key points (optional): Practitioner Points (optional) Authors will need to provide no more than 3 ‘key points’, written with the practitioner in mind, that summarize the key messages of their paper to be published with their article;

Main body: formatted as introduction, materials & methods (optional), results, discussion, conclusion. Throughout the paper, please check the usage of Latin, species, protein and gene symbols, abbreviations, and names. Content in Latin should be in italics. For species names in Latin, please use the full Latin name at the first mention and then use the abbreviation afterward. Protein abbreviations/symbols are normally in Roman font (upright type), while the gene symbols/names should be in italics, normally in upper case for human genes (e.g., CMH1 and HPR) and in lower case with an initial capital for animal genes (viz. mouse; e.g., Hras1 and Tcra);

Statements: Statements relating to our ethics and integrity policies, which may include any of the following (Why are these important? We need to uphold rigorous ethical standards for the research we consider for publication):

Author contributions: This journal encourages the CRediT (Contribution Roles Taxonomy)—more information is available on our Author Services This section is a required section to indicate contribution from each author;

Data availability statement: see Section 1.5 for details;

Acknowledgments: Please acknowledge the funding agencies if available, provide the full name (including country name) of the program and grant No. if possible. Please also acknowledge people who help with the study or manuscript preparation;

Conflict of interest: Cell Proliferationrequires that all authors disclose any potential sources of conflict of interest. Any interest or relationship, financial or otherwise that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. Potential sources of conflict of interest include, but are not limited to, patent or stock ownership, membership of a company board of directors, membership of an advisory board or committee for a company, and consultancy for or receipt of speaker's fees from a company. The existence of a conflict of interest does not preclude publication. If the authors have no conflict of interest to declare, they must also state this at submission. It is the responsibility of the corresponding author to review this policy with all authors and collectively to disclose with the submission ALL pertinent commercial and other relationships. The Conflict of Interest statement should be included within the main text file of your submission;

Ethics approval statement: This journal requires that you include in the manuscript details IRB approvals, ethical treatment of human and animal research participants, and gathering of informed consent, as appropriate. You will be expected to declare all conflicts of interest, or none, on submission. Please review Wiley’s policies surrounding human studies, animal studies, clinical trial registration, biosecurity, and research reporting guidelines;

This journal follows the core practices of the Committee on Publication Ethics (COPE) and handles cases of research and publication misconduct accordingly (https://publicationethics.org/core-practices);

This journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read Wiley’s Top 10 Publishing Ethics Tips for Authors and Wiley’s Publication Ethics Guidelines;

Patient consent statement;

Permission to reproduce material from other sources;

Clinical trial registration.

References: This journal uses AMA reference style. Review your reference style guidelines prior to submission. As this journal offers Free Format submission, however, this is for information only and you do not need to format the references in your article. This will instead be taken care of by the typesetter;

Tables: Tables should be self-contained and complement, not duplicate, information contained in the text. They should be supplied as editable files, not pasted as images. Legends should be concise but comprehensive – the table, legend, and footnotes must be understandable without reference to the text. All abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the headings;

Figures: Please review the Guidelines for the preparation of figuresfor manuscripts for peer review, as well as the more detailed post-acceptance figure requirements. If the figures are not of sufficiently high quality your manuscript may be delayed. Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.

1.11 Figures and Supporting Information

Figures, supporting information, and appendices should be supplied as separate files. You should review the basic figure requirements for manuscripts for peer review, as well as the more detailed post-acceptance figure requirements. View Wiley’s FAQs on supporting information.

1.12 Graphical TOC/Abstract

Graphical Abstract is mandatory for original article or review article, while optional for other article types. It is a single, concise visual summary of the main topics and if possible key findings of the article to draw the reader to the whole paper. In our submission system, you are required to submit the following items separately:

(1) A short statement of 50 words or less (1-2 sentences) to be published in the Table of Contents that describes the key findings and main message of the work. This caption will appear alongside the Graphical Abstract Image that you provide as a separate file.

(2) An illustration to be published in the Table of Contents to assist non-specialists in understanding the context and significance of your research. The image supplied should fit within the dimensions of 50 mm x 60 mm and be fully legible at this size. This image will be captioned with the Graphical Abstract Text that you supply as a separate file;

Graphical Abstracts can be shared and reproduced via all social media without limitation, for the benefit of spreading important research information.

Authors are responsible for obtaining permission to use any images that they include from outside sources, including articles, web pages, stock photo sites or Google image searches. Any needed permissions must be submitted along with your graphical abstract or identified in the Acknowledgements section of your manuscript.

1.13 LaTeX Guidelines for Submission

For authors requiring a LaTeX template, we strongly recommend reviewing Wiley’s New Journal Design (NJD) LaTeX Authoring Template.

LaTeX Guidelines for Post-Acceptance:

Please check that you have supplied the following files for typesetting post-acceptance:

PDF of the finalized source manuscript files compiled without any errors.

The LaTeX source code files (text, figure captions, and tables, preferably in a single file), BibTeX files (if used), any associated packages/files along with all other files needed for compiling without any errors. This is particularly important if authors have used any LaTeX style or class files, bibliography files (.bbl, .bst. .blg) or packages apart from those used in the NJD LaTeX Template class file.

Electronic graphics files for the illustrations in Encapsulated PostScript (EPS), PDF or TIFF format. Authors are requested not to create figures using LaTeX codes.

1.14 Peer Review

This journal operates a single-anonymized peer review policy. Except where otherwise stated, manuscripts are peer reviewed by at least two anonymous reviewers and an Associate or Assistant Editor. Papers will only be sent to review if the Editor-in-Chief determines that the paper meets the appropriate quality and relevance requirements.

In-house submissions, i.e. papers authored by Editors or Editorial Board members of the title, will be sent to Editors unaffiliated with the author or institution and monitored carefully to ensure there is no peer review bias.

Wiley's policy on the confidentiality of the review process is available here.

1.15 Refer and Transfer Program

Wiley believes that no valuable research should go unshared. This journal participates in Wiley’s Refer & Transfer program. If your manuscript is not accepted, you may receive a recommendation to transfer your manuscript to another suitable Wiley journal, either through a referral from the journal’s editor or through our Transfer Desk Assistant.

1.16 Appeals and Complaints

Authors may appeal an editorial decision if they feel that the decision to reject was based on either a significant misunderstanding of a core aspect of the manuscript, a failure to understand how the manuscript advances the literature or concerns regarding the manuscript-handling process. Differences in opinion regarding the novelty or significance of the reported findings are not considered as grounds for appeal. To raise an appeal, please contact this journal by email, quoting your manuscript ID number and explaining your rationale for the appeal. The editor’s decision following an appeal consideration is final.

To raise a complaint regarding editorial staff, policy or process please contact the journal in the first instance. If you believe further support outside the journal’s management is necessary, please refer to Wiley’s Best Practice Guidelines on Research Integrity and Publishing Ethics.

1.17 AI Policy

Artificial Intelligence Generated Content (AIGC) tools—such as ChatGPT and others based on large language models (LLMs)—cannot be considered capable of initiating an original piece of research without direction by human authors. They also cannot be accountable for a published work or for research design, which is a generally held requirement of authorship (as discussed in the previous section), nor do they have legal standing or the ability to hold or assign copyright. Therefore—in accordance with COPE’s position statement on AI tools—these tools cannot fulfill the role of, nor be listed as, an author of an article. If an author has used this kind of tool to develop any portion of a manuscript, its use must be described, transparently and in detail, in the Methods or Acknowledgements section. The author is fully responsible for the accuracy of any information provided by the tool and for correctly referencing any supporting work on which that information depends. Tools that are used to improve spelling, grammar, and general editing are not included in the scope of these guidelines. The final decision about whether use of an AIGC tool is appropriate or permissible in the circumstances of a submitted manuscript or a published article lies with the journal’s editor or other party responsible for the publication’s editorial policy.

......

更多详见：

https://onlinelibrary.wiley.com/page/journal/13652184/homepage/forauthors.html